BB

Bloomsbury Bioseed Fund

Europe, England, United Kingdom, London

Description

The Bloomsbury Bioseed Fund is a venture capital firm which invests through its fund The Bloomsbury Bioseed Fund.

Investor Profile

Bloomsbury Bioseed Fund has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United Kingdom.
  • Strong thematic focus on Health Care, Medical, Pharmaceutical.

Stage Focus

  • Series Unknown (50%)
  • Series A (50%)

Country Focus

  • United Kingdom (100%)

Industry Focus

  • Health Care
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Information Technology
  • Medical Device
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bloomsbury Bioseed Fund frequently co-invest with?

EV
Europe, Noord-Holland, The Netherlands, Hoofddorp
Co-Investments: 1
UCLB
Europe, England, United Kingdom, London
Co-Investments: 1
Sussex Place Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Wellcome Trust
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Bloomsbury Bioseed Fund?

Endomag

Cambridge, Cambridgeshire, United Kingdom

Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.

Health CareInformation TechnologyMedicalMedical DeviceOncology
Series AAug 5, 2011
Amount Raised: $1,960,429
Canbex Therapeutics

London, England, United Kingdom

Canbex Therapeutics is dedicated to treating spasticity in multiple sclerosis (MS) and other disorders.

Health CareMedicalPharmaceuticalTherapeutics
Series UnknownMar 23, 2011
Amount Raised: $2,843,508